Edoxaban vs Nivolumab

Edoxaban vs Nivolumab: Overview

This comparison examines the pharmacological differences between Edoxaban and Nivolumab.

Mechanism of Action

Edoxaban: Direct, selective inhibitor of Factor Xa preventing thrombin generation and clot formation.

Nivolumab: Fully human anti-PD-1 IgG4 monoclonal antibody restoring T-cell anti-tumor activity.

Pharmacokinetics

Half-life: Edoxaban — 10-14 hours; Nivolumab — 27 days.

Chemical Properties

Molecular Formula: Edoxaban — C24H30ClN7O4S.

Molecular Weight: Edoxaban — 548.0530 g/mol.

Type: Edoxaban — Small molecule; Nivolumab — Antibody.